Cas:155302-28-6 tert-butyl 4-(1H-indol-3-yl)piperidine-1-carboxylate manufacturer & supplier

Chemical Name:tert-butyl 4-(1H-indol-3-yl)piperidine-1-carboxylate

CAS.NO:155302-28-6

Synonyms:3-(N-tert-butyloxycarbonyl-piperidin-4-yl)-1H-indole;tert-butyl 4-(1H-indol-3-yl)-1-piperidinecarboxylate;4-(1H-indol-3-yl)-1-piperidinecarboxylic acid tert-butyl ester;tert-butyl 4-(1H-indol-3-yl)-piperidine-1-carboxylate;4-(1H-indol-3-yl)-1-tert-butyloxycarbonylpiperidine;4-(1H-indol-3-yl)-piperidine-1-carboxylic acid tert-butyl ester

Molecular Formula:C₁₈H₂₄N₂O₂

Molecular Weight:300.39500

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.149

Index of Refraction:

PSA:45.33000

Exact Mass:300.18400

LogP:4.22030

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-(N-tert-butyloxycarbonyl-piperidin-4-yl)-1H-indole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(1H-indol-3-yl)-piperidine-1-carboxylic acid tert-butyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(1H-indol-3-yl)-piperidine-1-carboxylic acid tert-butyl ester Use and application,4-(1H-indol-3-yl)-1-tert-butyloxycarbonylpiperidine technical grade,usp/ep/jp grade.

Related News: Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates. tert-butyl 4-(1H-indol-3-yl)piperidine-1-carboxylate manufacturer For one, people who are surrounded by others of similar body size may not perceive their weight to be outside of the norm and therefore not seek out bariatric surgery,” said Sandon. “[And] there are differences in ethnicities and culture between states with the highest rates of obesity compared to states with lower rates. tert-butyl 4-(1H-indol-3-yl)piperidine-1-carboxylate supplier There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association. tert-butyl 4-(1H-indol-3-yl)piperidine-1-carboxylate vendor In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available. tert-butyl 4-(1H-indol-3-yl)piperidine-1-carboxylate factory There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association.